Implementation of Smoking Cessation Support During Lung Cancer Workup

NCT05192031 — Not applicable, Completed, 86 participants, Vejle Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Implementation of Smoking Cessation Support During Lung Cancer Workup: a Pragmatic, Cluster-randomised Controlled Trial and an Interview-based Study of Patients' and Healthcare Professionals' Experiences

RegistryNCT05192031
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, supportive care
Enrollment86 (Actual)
SponsorVejle Hospital (Other); collaborators: Aalborg University Hospital, Aarhus University Hospital, University Hospital, Gentofte, Copenhagen, Naestved Hospital, Odense University Hospital, Zealand University Hospital, Bispebjerg Hospital, Hospital of Southern Jutland
ConditionsSuspected Lung Cancer
InterventionsSmoking cessation support (Behavioral)
Datesstart 2022-03-09, primary completion 2025-03-01, completion 2025-12-31, first posted 2022-01-14, last updated 2026-06-09
Locations1 site in Denmark

Related Papers Related Patents Related Grants Related Experts
All trials for Suspected Lung Cancer All trials of Smoking cessation support

-Summary

The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Smoking cessation supportExperimentalBehavioral: Smoking cessation support
Usual careNo intervention
  • Smoking cessation support (Behavioral): Training healthcare professionals to deliver smoking cessation support as part of hospital-based lung cancer workup.

+Outcome measures

Primary outcomes

  • Proportion of patients making an attempt at smoking cessation during lung cancer workup [6 weeks after baseline]: Binary outcome (Attempt: yes, no)

Secondary outcomes

  • Motivation to quit smoking [6 weeks, 3, 6, and 12 months after baseline]: Numeric rating scale (0-10) with higher score indicating stronger motivation
  • Proportion of patients who are not smoking at the time of measurement [6 weeks, 3, 6, and 12 months after baseline]: Binary outcome (Currently smoking: yes, no)
  • Quality of life as measured by the 36 item Short Form Survey (SF-36) [6 weeks, 3, 6, and 12 months after baseline]: SF-36, two components: Mental and Physical. Each components scale has a total score range from 5 (worst health) to 80 (best health)
  • Psychosocial consequences of lung cancer workup [6 weeks after baseline]: Consequences of Screening - Lung Cancer Questionnaire (adapted to the lung cancer workup setting). Items in Part 1 of the questionnaire focuses on experiences during the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 72 (high level of psychosocial consequences). Items in Part 2 of the questionnaire focuses on experiences after the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 22 (high level of psychosocial consequences).
  • Hospitals' number of referrals to municipality-based smoking cessation programmes [Change from one year before to one year after intervention]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Referred to lung cancer workup at participating hospital
* Able to speak and understand Danish

Exclusion Criteria:

* Unable to complete electronic questionnaires

+Locations (1)

FacilityCityCountryStatus
Vejle HospitalVejleDenmark

+Investigators

  • Anders Løkke, MD, Study director, Vejle Hospital, Lillebaelt Hospital
  • Ole Hilberg, Prof, Study director, Vejle Hospital, Lillebaelt Hospital